AI-generated summary
The authors systematically reviewed six databases for prospective clinical studies of photobiomodulation used to prevent or manage radiotherapy side effects. They report efficacy in randomized trials, especially for acute oral mucositis, acute radiation dermatitis and upper extremity lymphedema, but describe the overall level of evidence as heterogeneous and moderate. They also advise caution because long-term safety is not yet established.
- Who or what was studied
- Patients receiving radiotherapy who were studied for radiotherapy-related side effects
- Limits stated in the abstract
- The authors note heterogeneous evidence, diversity and lack of detail in treatment protocols, and that long-term safety has not been established.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.